October 2003

Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

Conditions:   Adult Acute Myeloid Leukemia in Remission;   Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Interventions:   Biological: filgrastim;   Biological: Anti-Thymocyte Globulin;   Drug: busulfan;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: tacrolimus;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
Active, not recruiting - verified February 2017